Clinical Trial Update: Combination Chemotherapy Plus Filgrastim in Treating Patients With Advanced Solid Tumors [Phase 1]

View source ↗

Summary

A Phase 1 trial from Dartmouth-Hitchcock Medical Center evaluated combining chemotherapy with filgrastim in patients with advanced solid tumors; the study has c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer
• Breast Cancer
• Carcinoma of Unknown Primary
• Esophageal Cancer
• Gastric Cancer
• Head and Neck Cancer
• Lung Cancer
• Melanoma

Drugs mentioned

• Neupogen (Filgrastim)

Snippet

Sponsor: Dartmouth-Hitchcock Medical Center | Conditions: Bladder Cancer, Breast Cancer | Phase 1 | Status: COMPLETED